288 related articles for article (PubMed ID: 19643985)
1. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.
Piconese S; Gri G; Tripodo C; Musio S; Gorzanelli A; Frossi B; Pedotti R; Pucillo CE; Colombo MP
Blood; 2009 Sep; 114(13):2639-48. PubMed ID: 19643985
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells.
Duan W; So T; Croft M
J Immunol; 2008 Dec; 181(12):8650-9. PubMed ID: 19050285
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.
Gri G; Piconese S; Frossi B; Manfroi V; Merluzzi S; Tripodo C; Viola A; Odom S; Rivera J; Colombo MP; Pucillo CE
Immunity; 2008 Nov; 29(5):771-81. PubMed ID: 18993084
[TBL] [Abstract][Full Text] [Related]
4. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
5. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
[TBL] [Abstract][Full Text] [Related]
7. Technical advance: soluble OX40 molecule mimics regulatory T cell modulatory activity on FcεRI-dependent mast cell degranulation.
Sibilano R; Gri G; Frossi B; Tripodo C; Suzuki R; Rivera J; MacDonald AS; Pucillo CE
J Leukoc Biol; 2011 Oct; 90(4):831-8. PubMed ID: 21653238
[TBL] [Abstract][Full Text] [Related]
8. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
Alharshawi K; Marinelarena A; Kumar P; El-Sayed O; Bhattacharya P; Sun Z; Epstein AL; Maker AV; Prabhakar BS
Sci Rep; 2017 Jul; 7(1):6594. PubMed ID: 28747670
[TBL] [Abstract][Full Text] [Related]
9. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
10. Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells.
Burocchi A; Pittoni P; Gorzanelli A; Colombo MP; Piconese S
Eur J Immunol; 2011 Dec; 41(12):3615-26. PubMed ID: 22229156
[TBL] [Abstract][Full Text] [Related]
11. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.
Foks AC; van Puijvelde GH; Bot I; ter Borg MN; Habets KL; Johnson JL; Yagita H; van Berkel TJ; Kuiper J
J Immunol; 2013 Nov; 191(9):4573-80. PubMed ID: 24068673
[TBL] [Abstract][Full Text] [Related]
12. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
Baeyens A; Saadoun D; Billiard F; Rouers A; Grégoire S; Zaragoza B; Grinberg-Bleyer Y; Marodon G; Piaggio E; Salomon BL
J Immunol; 2015 Feb; 194(3):999-1010. PubMed ID: 25548233
[TBL] [Abstract][Full Text] [Related]
13. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
Xiao X; Gong W; Demirci G; Liu W; Spoerl S; Chu X; Bishop DK; Turka LA; Li XC
J Immunol; 2012 Jan; 188(2):892-901. PubMed ID: 22147766
[TBL] [Abstract][Full Text] [Related]
14. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
[TBL] [Abstract][Full Text] [Related]
15. Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions.
Frossi B; D'Incà F; Crivellato E; Sibilano R; Gri G; Mongillo M; Danelli L; Maggi L; Pucillo CE
Eur J Immunol; 2011 Jul; 41(7):1872-82. PubMed ID: 21509780
[TBL] [Abstract][Full Text] [Related]
16. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
17. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
Kumar P; Marinelarena A; Raghunathan D; Ragothaman VK; Saini S; Bhattacharya P; Fan J; Epstein AL; Maker AV; Prabhakar BS
Cell Mol Immunol; 2019 Feb; 16(2):138-153. PubMed ID: 29578532
[TBL] [Abstract][Full Text] [Related]
18. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.
Kim MY; Anderson G; White A; Jenkinson E; Arlt W; Martensson IL; Erlandsson L; Lane PJ
J Immunol; 2005 Jun; 174(11):6686-91. PubMed ID: 15905508
[TBL] [Abstract][Full Text] [Related]
19. OX40 is required for regulatory T cell-mediated control of colitis.
Griseri T; Asquith M; Thompson C; Powrie F
J Exp Med; 2010 Apr; 207(4):699-709. PubMed ID: 20368580
[TBL] [Abstract][Full Text] [Related]
20. Modulation of FcεRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA.
Sibilano R; Frossi B; Suzuki R; D'Incà F; Gri G; Piconese S; Colombo MP; Rivera J; Pucillo CE
J Allergy Clin Immunol; 2012 Sep; 130(3):751-760.e2. PubMed ID: 22564682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]